Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Achilles Therapeutics plc ACHL

Set alert

Price alert · ACHL

All alert types
1.48 0.00 0.00%

At close · Mar 20

1.48 Day range 1.48

52-week range unavailable

YTD
+29.82%
1 year
+14.73%
Open
1.48
Prev close
1.48
Mkt cap
48.70M
Vol
1.20M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
1.48
High
1.48
Forward P/E
-0.61
Beta
1.34
Short ratio
1.69
Inst. own
59.30%
Dividend
0.00
Ex-div date
Earnings
Aug 14, 2024
50-d avg
1.02
200-d avg
0.91881
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ACHL has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-2.67 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.5×
FY 2018: -1.3×FY 2019: -0.8×FY 2020: -20.2×FY 2021: -2.4×FY 2022: -0.5×FY 2023: -0.5×
FY 2018 5y median -0.8× FY 2023
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
P/B 0.2×
FY 2018: 0.7×FY 2019: 0.1×FY 2020: 3.6×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.2×
FY 2018 5y median 0.2× FY 2023
P/FCF -0.7×
FY 2018: -1142×FY 2019: -0.7×FY 2020: -18.1×FY 2021: -2.1×FY 2022: -0.5×FY 2023: -0.7×
FY 2018 5y median -0.7× FY 2023
EV/EBITDA 1.3×
FY 2018: 0.3×FY 2019: 6.4×FY 2020: -15.5×FY 2021: 1.8×FY 2022: 1.9×FY 2023: 1.3×
FY 2018 5y median 1.8× FY 2023
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
FCF Yield -139.4%
FY 2018: -0.1%FY 2019: -133.5%FY 2020: -5.5%FY 2021: -46.6%FY 2022: -190.3%FY 2023: -139.4%
FY 2018 5y median -133.5% FY 2023

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
ROE -48.9%
FY 2018: -54.3%FY 2019: -13.8%FY 2020: -17.5%FY 2021: -21.1%FY 2022: -36.1%FY 2023: -48.9%
FY 2018 5y median -21.1% FY 2023
ROIC -50.8%
FY 2018: -54.5%FY 2019: -13.5%FY 2020: -16.4%FY 2021: -21.2%FY 2022: -37.9%FY 2023: -50.8%
FY 2018 5y median -21.2% FY 2023
ROA -43.1%
FY 2018: -49.3%FY 2019: -13.3%FY 2020: -15.2%FY 2021: -19.3%FY 2022: -32.3%FY 2023: -43.1%
FY 2018 5y median -19.3% FY 2023

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 FY 2023
Operating Income 4.0%
FY 2018: 0.0%FY 2019: -99.6%FY 2020: -144.8%FY 2021: -90.3%FY 2022: -22.1%FY 2023: 4.0%
FY 2018 FY 2023
EPS (diluted) 4.4%
FY 2018: 0.0%FY 2019: -61.4%FY 2020: 96.0%FY 2021: -159.8%FY 2022: 14.6%FY 2023: 4.4%
FY 2018 FY 2023
Free Cash Flow 26.1%
FY 2018: 0.0%FY 2019: -191906.1%FY 2020: -145.9%FY 2021: -80.4%FY 2022: -0.2%FY 2023: 26.1%
FY 2018 FY 2023

Financial Health

Current Ratio 8.6×
FY 2018: 10.4×FY 2019: 26.7×FY 2020: 11.3×FY 2021: 14.9×FY 2022: 10.9×FY 2023: 8.6×
FY 2018 5y median 11.3× FY 2023
Quick Ratio 8.6×
FY 2018: 10.4×FY 2019: 26.6×FY 2020: 11.3×FY 2021: 14.6×FY 2022: 10.7×FY 2023: 8.6×
FY 2018 5y median 11.3× FY 2023
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023
Net Debt / EBITDA 1.8×
FY 2018: 1.6×FY 2019: 7.2×FY 2020: 4.9×FY 2021: 4.2×FY 2022: 2.4×FY 2023: 1.8×
FY 2018 5y median 4.2× FY 2023
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×
FY 2018 5y median 0.0× FY 2023

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%
FY 2018 5y median 0.0% FY 2023

Annual · latest fiscal year ends 2023-12-31